Literature DB >> 22130918

Primary human osteoblast cultures.

Jane P Dillon1, Victoria J Waring-Green, Adam M Taylor, Peter J M Wilson, Mark Birch, Alison Gartland, James A Gallagher.   

Abstract

Osteoblast cultures can be used to investigate the mechanisms of bone formation, to probe the cellular and molecular basis of bone disease, and to screen for potential therapeutic agents that affect bone formation. Here, we describe the methods for establishing and characterising primary human osteoblast cultures.

Entities:  

Mesh：

Year:  2012        PMID： 22130918     DOI： 10.1007/978-1-61779-415-5_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  12 in total

1.  Generation of rodent and human osteoblasts.

Authors:  Sarah E B Taylor; Mittal Shah; Isabel R Orriss
Journal:  Bonekey Rep       Date:  2014-11-12

2.  Protein kinase G and focal adhesion kinase converge on Src/Akt/β-catenin signaling module in osteoblast mechanotransduction.

Authors:  Hema Rangaswami; Raphaela Schwappacher; Trish Tran; Geraldine C Chan; Shunhui Zhuang; Gerry R Boss; Renate B Pilz
Journal:  J Biol Chem       Date:  2012-05-04       Impact factor: 5.157

3.  Isolation of primary osteoblast cell lines from adult rat and rat embryos and their use as models for in vitro biocompatibility tests of nanostructured titanium-based implants.

Authors:  Y Y Khrunyk; I V Vyalykh; A V Korelin; S V Belikov; M S Karabanalov; S B Rakitin; R V Kamalov; A A Popov
Journal:  Dokl Biol Sci       Date:  2017-09-01

4.  Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.

Authors:  S Zafar; D E Coates; M P Cullinan; B K Drummond; T Milne; G J Seymour
Journal:  Clin Oral Investig       Date:  2016-01-22       Impact factor: 3.573

5.  Defining the Properties of an Array of -NH2-Modified Substrates for the Induction of a Mature Osteoblast/Osteocyte Phenotype from a Primary Human Osteoblast Population Using Controlled Nanotopography and Surface Chemistry.

Authors:  Sandra A Fawcett; Judith M Curran; Rui Chen; Nicholas P Rhodes; Mark F Murphy; Peter Wilson; Lakshminarayan Ranganath; Jane P Dillon; James A Gallagher; John A Hunt
Journal:  Calcif Tissue Int       Date:  2016-10-28       Impact factor: 4.333

6.  Direct comparison of 3D and 2D cultivation reveals higher osteogenic capacity of elderly osteoblasts in 3D.

Authors:  Stephan Payr; Elizabeth Rosado-Balmayor; Thomas Tiefenboeck; Tim Schuseil; Marina Unger; Claudine Seeliger; Martijn van Griensven
Journal:  J Orthop Surg Res       Date:  2021-01-06       Impact factor: 2.359

7.  Prostaglandin EP4 Selective Agonist AKDS001 Enhances New Bone Formation by Minimodeling in a Rat Heterotopic Xenograft Model of Human Bone.

Authors:  Yuichiro Ukon; Masahiro Nishida; Natsumi Yamamori; Kazuhiro Takeyama; Kazuhito Sakamoto; Shota Takenaka; Takahiro Makino; Takahito Fujimori; Yusuke Sakai; Yuya Kanie; Joe Kodama; Zeynep Bal; Daisuke Tateiwa; Shinichi Nakagawa; Hiromasa Hirai; Seiji Okada; Takashi Kaito
Journal:  Front Bioeng Biotechnol       Date:  2022-03-17

8.  Optimisation of the differing conditions required for bone formation in vitro by primary osteoblasts from mice and rats.

Authors:  Isabel R Orriss; Mark O R Hajjawi; Carmen Huesa; Vicky E MacRae; Timothy R Arnett
Journal:  Int J Mol Med       Date:  2014-09-08       Impact factor: 4.101

9.  Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts.

Authors:  Tanja Niedermair; Stephan Schirner; Raphael Seebröker; Rainer H Straub; Susanne Grässel
Journal:  Sci Rep       Date:  2018-06-15       Impact factor: 4.379

10.  Enhanced p53 Levels Are Involved in the Reduced Mineralization Capacity of Osteoblasts Derived from Shwachman-Diamond Syndrome Subjects.

Authors:  Annalisa Frattini; Simona Bolamperti; Roberto Valli; Marco Cipolli; Rita Maria Pinto; Elena Bergami; Maria Rita Frau; Simone Cesaro; Michela Signo; Valentino Bezzerri; Giovanni Porta; Abdul Waheed Khan; Alessandro Rubinacci; Isabella Villa
Journal:  Int J Mol Sci       Date:  2021-12-11       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.